600 Participants Needed

Telehealth Interventions for Diabetes

(ACCTiVATE Trial)

AV
AR
Overseen ByAndy Ramirez, BS
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of California, San Francisco
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It focuses on improving telehealth access for managing diabetes and other chronic conditions.

What data supports the effectiveness of the treatment Digital Health Coaching, Digital Health Coaching, Remote Monitoring and Coaching, Telehealth Coaching, Practice Facilitation for diabetes?

Research shows that digital health coaching can significantly improve insulin resistance in patients with type 2 diabetes, making it a promising approach for managing the condition. Additionally, telehealth systems that include health coaching and remote monitoring have been effective in managing chronic diseases by supporting behavior change and overcoming barriers to accessing care.12345

Is telehealth coaching safe for humans?

Telehealth coaching, including digital health coaching and remote monitoring, has been used safely in various studies for managing chronic conditions like diabetes and obesity. Participants generally report high satisfaction and no significant safety concerns have been noted in the research.46789

How is the telehealth treatment for diabetes different from other treatments?

The telehealth treatment for diabetes is unique because it uses smartphone technology and connected devices for remote blood glucose monitoring, along with virtual coaching and support. This approach allows for personalized, scalable, and effective management of diabetes, especially for under-resourced patients, by focusing on lifestyle and behavioral changes.1241011

What is the purpose of this trial?

This study examines the impact of a multi-level intervention aiming to improve telehealth access for low-income patients managing chronic health conditions, such as hypertension and diabetes. The multi-level intervention includes clinic-level practice facilitation and patient-level digital health coaching.

Research Team

DT

Delphine Tuot, MD MAS

Principal Investigator

University of California, San Francisco

Eligibility Criteria

This trial is for low-income patients managing chronic conditions like hypertension and diabetes. It aims to improve their access to telehealth services.

Inclusion Criteria

My last A1C level was 8.0% or higher, indicating my diabetes is not well-controlled.
At least 1 visit at a participating SFHN primary care site in the last 24 months

Exclusion Criteria

Visual or hearing impairment that precludes use of telehealth for chronic disease management
Presence of co-morbid conditions that would make it inappropriate to focus on telehealth chronic disease management. Conditions may include: end-stage or terminal condition with limited life expectancy and severe mental illness
I do not have a working phone number.
See 3 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants receive digital coaching and clinics receive practice facilitation to improve telehealth access and chronic disease management

24 months
Regular virtual and in-person visits as needed

Follow-up

Participants are monitored for clinical outcomes and digital literacy improvements

6 months
Periodic virtual check-ins

Treatment Details

Interventions

  • Digital Health Coaching
  • Practice Facilitation
Trial Overview The study tests a multi-level intervention that includes practice facilitation at the clinic level and digital health coaching for patients, focusing on enhancing telehealth use.
Participant Groups
4Treatment groups
Experimental Treatment
Active Control
Group I: Patient Usual Care + Clinic InterventionExperimental Treatment1 Intervention
Usual Care (Patient-Level) + Clinic Intervention
Group II: Patient Intervention + Clinic Usual CareExperimental Treatment1 Intervention
Digital coach navigator + Clinic Usual Care
Group III: Patient Intervention + Clinic InterventionExperimental Treatment2 Interventions
Digital coach navigator + Clinic Intervention
Group IV: Patient Usual Care + Clinic Usual CareActive Control1 Intervention
Usual Care (Patient-Level) + Clinic Usual Care

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of California, San Francisco

Lead Sponsor

Trials
2,636
Recruited
19,080,000+

San Francisco Tech Council

Collaborator

Trials
1
Recruited
600+

National Institute on Minority Health and Health Disparities (NIMHD)

Collaborator

Trials
473
Recruited
1,374,000+

Findings from Research

The integration of smart insulin pens and other connected devices into diabetes care can enhance remote monitoring and virtual care, providing a more data-driven clinical practice model.
As healthcare evolves, there is increasing interest from patients and healthcare teams in utilizing these technologies to improve diabetes management and treatment outcomes.
Building a Data-Driven Multiple Daily Insulin Therapy Model Using Smart Insulin Pens.Harbison, R., Hecht, M., MacLeod, J.[2022]
The 12-week Healthy at Home digital health coaching program significantly improved insulin resistance in individuals with type 2 diabetes, showing a reduction in HOMA2-IR scores compared to usual care (p = 0.029).
This pilot study suggests that digital health coaching can be an effective and accessible intervention for under-resourced patients with type 2 diabetes, potentially leading to better diabetes management and clinical outcomes.
Digital Health Coaching for Type 2 Diabetes: Randomized Controlled Trial of Healthy at Home.Azelton, KR., Crowley, AP., Vence, N., et al.[2021]
Patients showed high initial acceptance of automated telephonic assessment (ATA) calls for depression monitoring, with 89.6% willing to use them at 6 months, but this willingness decreased to 51.0% by 18 months, indicating a decline in perceived usefulness over time.
Key factors influencing long-term acceptance of ATA calls included perceptions of privacy/security and the ongoing usefulness of the system, suggesting that maintaining patient engagement requires continuous adaptation to their needs.
Automated Remote Monitoring of Depression: Acceptance Among Low-Income Patients in Diabetes Disease Management.Ramirez, M., Wu, S., Jin, H., et al.[2022]

References

Building a Data-Driven Multiple Daily Insulin Therapy Model Using Smart Insulin Pens. [2022]
Digital Health Coaching for Type 2 Diabetes: Randomized Controlled Trial of Healthy at Home. [2021]
Automated Remote Monitoring of Depression: Acceptance Among Low-Income Patients in Diabetes Disease Management. [2022]
The Use of Telehealth Technology to Support Health Coaching for Older Adults: Literature Review. [2021]
Telehealth methods to deliver dietary interventions in adults with chronic disease: a systematic review and meta-analysis. [2023]
Virtual Coaching to Enhance Diabetes Care. [2020]
Health coaching and genetic risk testing in primary care: Randomized controlled trial. [2022]
A Mobile Phone-Based Health Coaching Intervention for Weight Loss and Blood Pressure Reduction in a National Payer Population: A Retrospective Study. [2019]
Outcomes of a Digital Health Program With Human Coaching for Diabetes Risk Reduction in a Medicare Population. [2022]
Reporting of Telehealth-Delivered Dietary Intervention Trials in Chronic Disease: Systematic Review. [2023]
A care team-based classification and population management schema for connected diabetes care. [2023]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security